FDA Inspection
Ascension SetonAscension Seton – FDA Inspection, Jan 20, 2016
Record Details
This FDA Inspection record concerns Ascension Seton, with an inspection on January 20, 2016, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Ascension Seton
- Inspection Date
- January 20, 2016
- Product Type
- Biologics
View Company Profile
ID · 88cd6ff5-c2ed-41f0-b171-b518ba29d79c
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 960814
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Ascension Seton
7| Date | Classification | Office | Project area |
|---|---|---|---|
| July 25, 2025 | Not classified | Dallas District Office | |
| March 11, 2022 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 8, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 23, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 11, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Ascension Seton
- FDA Inspection 1278262 - 2025-07-25
- FDA Inspection 1164613 - 2022-03-11
- FDA Inspection 1056476 - 2018-06-08
- FDA Inspection 888156 - 2014-07-23
- FDA Inspection 802770 - 2012-10-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.